A high plasma level of factor VIII is a risk factor for venous thromboembolism. We evaluated the risk of a recurrence of thrombosis after an initial episode of spontaneous venous thromboembolism am ...

Anti-factor Xa values in morbidly obese patients receiving standard doses of fondaparinux sodium for the prevention of venous thromboembolism (VTE) were analyzed in a retrospective chart evaluation.

Once-daily oral rivaroxaban is superior to once-daily subcutaneous enoxaparin in preventing venous thromboembolism and death after total hip and knee arthroplasty.